(Q35125188)

6 August 2017

title

Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro (English)

1 reference

Helicobacter pylori infectious disease

6 August 2017

0 references

1 reference

Midolo PD

1

1 reference

6 August 2017

Turnidge JD

series ordinal

2

1 reference

6 August 2017

Lambert JR

series ordinal

3

1 reference

6 August 2017

Bell JM

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

40

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

1531-1533

1 reference

Reduced amoxicillin uptake into human gastric mucosa when gastric juice pH is high

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163362

Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163362

The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163362

Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163362

Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163362

Lack of in vitro activity of omeprazole against Campylobacter pylori

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163362

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163362

Effects of environmental factors on the in vitro potency of azithromycin.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163362

The mechanism of action of the gastric acid secretion inhibitor omeprazole

13 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8726032

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antibacterial activity of pantoprazole and omeprazole againstHelicobacter pylori

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8726032

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8726032

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.40.6.1531

0 references

PMC publication ID

163362

1 reference

6 August 2017

1 reference